Evogene Ltd.
USD0.43
-0.01 (-1.16%)
CEO
Ofer Haviv
IPO Date
2010-10-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Open
$0.42
Prev. Close
$0.43
Day Low
$0.41
Day High
$0.44
52W Low
$0.37
52W High
$1.50
Market Cap
$0.00B
Volume
0.13M
| -0.7 |
| 31 Dec 2023 | FY | 70.0% | -423.4% | -198.1% | -46.7% | 0.95 | 4.96 | -15.8 |
| 31 Dec 2022 | FY | 45.7% | -1781.7% | -106.9% | -53.2% | 0.43 | 6.71 | -8.8 |
| 31 Dec 2021 | FY | 17.5% | -3273.7% | -56.3% | -39.9% | 0.05 | 8.27 | -23.0 |
| 31 Dec 2020 | FY | 44.8% | -2519.8% | -56.9% | -36.4% | 0.05 | 5.36 | -51.6 |
| 31 Dec 2019 | FY | 55.6% | -2538.5% | -38.1% | -26.8% | 0.06 | 8.56 | -20.5 |
| 31 Dec 2018 | FY | 16.9% | -1188.2% | -41.5% | -35.4% | 0.00 | 10.22 | -25.8 |
| 31 Dec 2017 | FY | 15.9% | -616.3% | -30.0% | -26.9% | 0.00 | 15.61 | -40.0 |
| 31 Dec 2016 | FY | 13.8% | -299.6% | -22.4% | -20.4% | 0.00 | 17.13 | -66.7 |
| -0.4 |
| 30 Sept 2025 | Q3 | -40.4% | 1241.7% | 339.2% | 14.9% | 2.21 | 4.92 | 0.7 |
| 30 Jun 2025 | Q2 | 84.6% | -504.8% | 125.7% | -13.2% | -3.57 | 1.89 | -0.5 |
| 31 Mar 2025 | Q1 | 34.0% | -105.9% | 71.0% | -7.5% | -3.56 | 1.06 | -0.8 |
| 31 Dec 2024 | Q4 | 53.1% | 26.5% | -29.4% | 1.1% | -8.87 | 1.15 | 6.8 |
| 30 Sept 2024 | Q3 | 39.8% | -424.8% | 175.7% | -19.0% | -2.53 | 1.09 | -0.6 |
| 30 Jun 2024 | Q2 | 41.2% | -592.9% | -176.7% | -13.2% | 3.65 | 1.58 | -15.0 |
| 31 Mar 2024 | Q1 | 92.6% | -92.2% | -46.6% | -8.3% | 1.37 | 5.06 | -25.0 |
| 31 Dec 2023 | Q4 | 31.1% | -1142.0% | -54.8% | -12.9% | 0.95 | 4.96 | -15.8 |